India OKs AstraZeneca and locally-made COVID-19 vaccines

NEW DELHI (AP) — India has authorized two COVID-19 vaccines, paving the way for a huge inoculation program to stem the coronavirus pandemic in the world’s second most populous country. India’s drugs regulator on Sunday gave an emergency authorization for the vaccines developed by Oxford University and U.K.-based drugmaker AstraZeneca and another by the Indian company Bharat Biotech. India’s initial immunization plan aims to vaccinate 300 million people — health care